The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatment

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/29287

Title:	The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatment
Authors:	Marcellin, Patrick Bonino, Ferruccio Lau, George Farci, Patrizia Yurdaydin, C. Piratvisuth, Teerha Jin, R. Hadziyannis, Stephanos J. Lu, Zhimeng Popescu, Madalina Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı. Gürel, Selim
Keywords:	Gastroenterology & hepatology
Issue Date:	2006
Publisher:	Elsevier
Citation:	Marcellin, P. vd. (2006). ''The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatment''. Journal of hepatology, 44(Suplement 2), S275-S275.
Description:	Bu çalışma, 26-30 Nisan 2006 tarihleri arasında Vienna[Avusturya]’da düzenlenen 41. Annual Meeting of the European-Association-for-the-Study-of-the-Liver’da bildiri olarak sunulmuştur.
URI:	https://doi.org/10.1016/S0168-8278(06)80744-0 https://www.sciencedirect.com/science/article/pii/S0168827806807440 http://hdl.handle.net/11452/29287
ISSN:	0168-8278
Appears in Collections:	Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI